STOCK TITAN

Confluent, Inc. Financials

CFLT
Source SEC Filings (10-K/10-Q) Data as of Dec 31, 2025 Currency USD FYE December

This page shows Confluent, Inc. (CFLT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CFLT FY2025

Scale is steadily converting a high-gross-margin software model from cash burn toward self-funded operations despite continuing GAAP losses.

From FY2023 to FY2025, gross margin expansion from 70.4% to 74.3% and free cash flow turning from negative to $60.7M positive happened even as R&D spending rose to $481.7M. That combination suggests the business is not improving mainly by cutting muscle; added revenue is increasingly absorbing fixed operating costs inside a still loss-making model.

FY2025 capex was only $3.6M against operating cash flow of $64.3M, so this is an asset-light model where free cash flow now sits close to operating cash flow. That matters because the company still posted a net loss of -$295.3M, meaning cash generation has improved faster than accounting earnings.

The balance sheet still carries about $1.10B of long-term debt, but leverage is easing because that debt has stayed roughly flat while equity grew to $1.17B, bringing debt-to-equity down to 0.9x from 1.4x in FY2022. Cash of $347.2M is much lower than the FY2021 post-IPO level, yet a 3.8x current ratio indicates near-term liquidity is not the main operating constraint.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 52 / 100
Financial Health Score 52/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Confluent, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
27

Confluent, Inc. has an operating margin of -32.6%, meaning the company retains $-33 of operating profit per $100 of revenue. This below-average margin results in a low score of 27/100, suggesting thin profitability after operating expenses. This is up from -43.5% the prior year.

Growth
84

Confluent, Inc.'s revenue surged 21.1% year-over-year to $1.2B, reflecting rapid business expansion. This strong growth earns a score of 84/100.

Leverage
48

Confluent, Inc. has a moderate D/E ratio of 0.94. This balance of debt and equity financing earns a leverage score of 48/100.

Liquidity
85

With a current ratio of 3.83, Confluent, Inc. holds $3.83 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 85/100.

Cash Flow
31

Confluent, Inc. has a free cash flow margin of 5.2%, earning a moderate score of 31/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
37

Confluent, Inc.'s ROE of -25.3% shows moderate profitability relative to equity, earning a score of 37/100. This is up from -35.9% the prior year.

Altman Z-Score Safe
3.35

Confluent, Inc. scores 3.35, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($11.1B) relative to total liabilities ($1.8B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
6/8

Confluent, Inc. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed
-0.22x

For every $1 of reported earnings, Confluent, Inc. generates $-0.22 in operating cash flow ($64.3M OCF vs -$295.3M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.2B
YoY+21.1%
5Y CAGR+37.6%

Confluent, Inc. generated $1.2B in revenue in fiscal year 2025. This represents an increase of 21.1% from the prior year.

EBITDA
-$350.5M
YoY+11.7%

Confluent, Inc.'s EBITDA was -$350.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 11.7% from the prior year.

Net Income
-$295.3M
YoY+14.4%

Confluent, Inc. reported -$295.3M in net income in fiscal year 2025. This represents an increase of 14.4% from the prior year.

EPS (Diluted)
$-0.86
YoY+19.6%

Confluent, Inc. earned $-0.86 per diluted share (EPS) in fiscal year 2025. This represents an increase of 19.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$60.7M
YoY+96.4%

Confluent, Inc. generated $60.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 96.4% from the prior year.

Cash & Debt
$347.2M
YoY-10.0%
5Y CAGR+56.7%

Confluent, Inc. held $347.2M in cash against $1.1B in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
N/A

Margins & Returns

Gross Margin
74.3%
YoY+1.0pp
5Y CAGR+6.2pp

Confluent, Inc.'s gross margin was 74.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.0 percentage points from the prior year.

Operating Margin
-32.6%
YoY+10.9pp
5Y CAGR+66.0pp

Confluent, Inc.'s operating margin was -32.6% in fiscal year 2025, reflecting core business profitability. This is up 10.9 percentage points from the prior year.

Net Margin
-25.3%
YoY+10.5pp
5Y CAGR+71.8pp

Confluent, Inc.'s net profit margin was -25.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 10.5 percentage points from the prior year.

Return on Equity
-25.3%
YoY+10.6pp

Confluent, Inc.'s ROE was -25.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 10.6 percentage points from the prior year.

Capital Allocation

R&D Spending
$481.7M
YoY+14.4%
5Y CAGR+35.5%

Confluent, Inc. invested $481.7M in research and development in fiscal year 2025. This represents an increase of 14.4% from the prior year.

Share Buybacks
N/A
Capital Expenditures
$3.6M
YoY+40.1%
5Y CAGR+28.2%

Confluent, Inc. invested $3.6M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 40.1% from the prior year.

CFLT Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Revenue $314.8M+5.5% $298.5M+5.8% $282.3M+4.1% $271.1M+3.8% $261.2M+4.4% $250.2M+6.5% $235.0M+8.2% $217.2M
Cost of Revenue $79.7M+3.5% $77.0M+3.8% $74.2M+7.3% $69.1M+2.3% $67.6M+6.1% $63.7M-2.0% $65.0M+6.1% $61.2M
Gross Profit $235.2M+6.1% $221.6M+6.5% $208.1M+3.0% $202.0M+4.3% $193.7M+3.8% $186.5M+9.7% $170.0M+9.0% $156.0M
R&D Expenses $121.9M+0.1% $121.8M+0.4% $121.2M+3.8% $116.8M+1.7% $114.9M+11.8% $102.7M-3.1% $106.1M+8.7% $97.6M
SG&A Expenses $52.6M+30.5% $40.3M+1.5% $39.7M-1.0% $40.1M+1.9% $39.4M-0.3% $39.5M+0.1% $39.4M+2.6% $38.4M
Operating Income -$99.2M-19.0% -$83.3M+13.6% -$96.4M+4.7% -$101.2M+4.4% -$105.8M-12.9% -$93.7M+13.6% -$108.3M+2.7% -$111.4M
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax -$393K-125.3% $1.6M-76.5% $6.6M+150.2% -$13.2M-946.9% $1.6M-47.6% $3.0M-12.6% $3.4M+38.0% $2.5M
Net Income -$79.2M-19.2% -$66.5M+18.8% -$82.0M-21.3% -$67.6M+23.3% -$88.1M-18.8% -$74.1M+17.5% -$89.9M+3.3% -$93.0M
EPS (Diluted) N/A $-0.19+20.8% $-0.24-20.0% $-0.20 N/A $-0.23+17.9% $-0.28+6.7% $-0.30

CFLT Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Total Assets $3.0B+3.8% $2.9B+2.1% $2.8B+4.4% $2.7B+0.1% $2.7B+3.3% $2.6B+3.1% $2.5B+3.6% $2.4B
Current Assets $2.6B+4.3% $2.5B+2.3% $2.4B+4.2% $2.3B-0.4% $2.4B+3.8% $2.3B-1.8% $2.3B+3.6% $2.2B
Cash & Equivalents $347.2M+16.3% $298.5M+1.0% $295.6M+6.1% $278.6M-27.8% $386.0M+19.6% $322.6M+3.6% $311.3M-7.4% $336.4M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable $390.8M+9.6% $356.4M-0.3% $357.6M+20.1% $297.9M-5.2% $314.3M+12.8% $278.7M+8.2% $257.5M+28.8% $199.8M
Goodwill $164.4M0.0% $164.4M0.0% $164.4M0.0% $164.4M0.0% $164.4M0.0% $164.4M+216.1% $52.0M0.0% $52.0M
Total Liabilities $1.8B+3.3% $1.8B+0.3% $1.8B+4.8% $1.7B-3.5% $1.7B+3.6% $1.7B+1.2% $1.7B+3.8% $1.6B
Current Liabilities $680.6M+9.3% $622.6M+1.6% $612.9M+15.7% $529.9M-10.1% $589.2M+10.1% $535.0M+2.8% $520.2M+18.4% $439.2M
Long-Term Debt $1.1B+0.1% $1.1B+0.1% $1.1B+0.1% $1.1B+0.1% $1.1B+0.1% $1.1B+0.1% $1.1B+0.1% $1.1B
Total Equity $1.2B+4.5% $1.1B+5.2% $1.1B+3.7% $1.0B+6.7% $961.2M+2.9% $934.3M+6.9% $873.9M+3.4% $845.2M
Retained Earnings -$2.3B-3.6% -$2.2B-3.1% -$2.1B-4.0% -$2.1B-3.4% -$2.0B-4.6% -$1.9B-4.1% -$1.8B-5.2% -$1.7B

CFLT Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Operating Cash Flow $42.1M+36.7% $30.8M+70.0% $18.1M+167.7% -$26.8M-176.0% $35.2M+125.5% $15.6M+81.8% $8.6M+133.1% -$26.0M
Capital Expenditures $442K-45.2% $807K-12.2% $919K-35.7% $1.4M+113.6% $669K+10.2% $607K-45.1% $1.1M+494.1% $186K
Free Cash Flow $41.7M+38.9% $30.0M+74.4% $17.2M+161.0% -$28.2M-181.6% $34.5M+130.2% $15.0M+100.5% $7.5M+128.6% -$26.1M
Investing Cash Flow -$17.8M+62.0% -$46.8M-450.7% -$8.5M+92.4% -$112.0M-1192.9% $10.2M+146.7% -$21.9M+52.9% -$46.5M-177.5% -$16.8M
Financing Cash Flow $24.6M+24.2% $19.8M+226.2% $6.1M-80.3% $30.8M+57.9% $19.5M+13.4% $17.2M+31.4% $13.1M-56.4% $30.0M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

CFLT Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Gross Margin 74.7%+0.5pp 74.2%+0.5pp 73.7%-0.8pp 74.5%+0.4pp 74.1%-0.4pp 74.5%+2.2pp 72.4%+0.5pp 71.8%
Operating Margin -31.5%-3.6pp -27.9%+6.3pp -34.2%+3.2pp -37.3%+3.2pp -40.5%-3.1pp -37.4%+8.7pp -46.1%+5.1pp -51.3%
Net Margin -25.2%-2.9pp -22.3%+6.8pp -29.0%-4.1pp -24.9%+8.8pp -33.7%-4.1pp -29.6%+8.6pp -38.3%+4.5pp -42.8%
Return on Equity -6.8%-0.8pp -5.9%+1.8pp -7.7%-1.1pp -6.6%+2.6pp -9.2%-1.2pp -7.9%+2.4pp -10.3%+0.7pp -11.0%
Return on Assets -2.6%-0.3pp -2.3%+0.6pp -2.9%-0.4pp -2.5%+0.8pp -3.3%-0.4pp -2.8%+0.7pp -3.6%+0.3pp -3.8%
Current Ratio 3.83-0.2 4.01+0.0 3.98-0.4 4.42+0.4 3.99-0.2 4.24-0.2 4.44-0.6 5.07
Debt-to-Equity 0.94-0.0 0.98-0.0 1.03-0.0 1.07-0.1 1.14-0.0 1.17-0.1 1.25-0.0 1.29
FCF Margin 13.2%+3.2pp 10.1%+4.0pp 6.1%+16.5pp -10.4%-23.6pp 13.2%+7.2pp 6.0%+2.8pp 3.2%+15.2pp -12.0%

Similar Companies

Frequently Asked Questions

Confluent, Inc. (CFLT) reported $1.2B in total revenue for fiscal year 2025. This represents a 21.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Confluent, Inc. (CFLT) revenue grew by 21.1% year-over-year, from $963.6M to $1.2B in fiscal year 2025.

No, Confluent, Inc. (CFLT) reported a net income of -$295.3M in fiscal year 2025, with a net profit margin of -25.3%.

Confluent, Inc. (CFLT) reported diluted earnings per share of $-0.86 for fiscal year 2025. This represents a 19.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Confluent, Inc. (CFLT) had EBITDA of -$350.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Confluent, Inc. (CFLT) had $347.2M in cash and equivalents against $1.1B in long-term debt.

Confluent, Inc. (CFLT) had a gross margin of 74.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Confluent, Inc. (CFLT) had an operating margin of -32.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Confluent, Inc. (CFLT) had a net profit margin of -25.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Confluent, Inc. (CFLT) has a return on equity of -25.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Confluent, Inc. (CFLT) generated $60.7M in free cash flow during fiscal year 2025. This represents a 96.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Confluent, Inc. (CFLT) generated $64.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Confluent, Inc. (CFLT) had $3.0B in total assets as of fiscal year 2025, including both current and long-term assets.

Confluent, Inc. (CFLT) invested $3.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Confluent, Inc. (CFLT) invested $481.7M in research and development during fiscal year 2025.

Confluent, Inc. (CFLT) had a current ratio of 3.83 as of fiscal year 2025, which is generally considered healthy.

Confluent, Inc. (CFLT) had a debt-to-equity ratio of 0.94 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Confluent, Inc. (CFLT) had a return on assets of -9.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Confluent, Inc. (CFLT) has an Altman Z-Score of 3.35, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Confluent, Inc. (CFLT) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Confluent, Inc. (CFLT) has an earnings quality ratio of -0.22x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Confluent, Inc. (CFLT) scores 52 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top